Copyright © Inderes 2011 - present. All rights reserved.
Logga in för att få aviseringar
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Analytikerkommentar

Scanfil Q4'24 flash comment: Forecasts roughly in the middle of the guidance range

Av Antti ViljakainenHead of Research
2025-02-21 09:16
Scanfil

Translation: Original published in Finnish on 02/21/2025 at 09:12 am EET

Scanfil210224

Scanfil released its Q4 report this morning. The surprise element related to the Q4 figures was very small due to the narrowed guidance in December, and the development in late 2024 was practically in line with our expectations. Scanfil plans to raise its dividend for the 12th year in a row, although the increase is in practice the smallest possible. For this year, Scanfil's guidance ranges indicate revenue and earnings growth, both our and consensus forecasts lie within these ranges. Thus, at first glance, we believe Scanfil's Q4 report met expectations and we do not initially expect that the report will cause major changes to our or consensus estimates for the near term. 

Organic revenue contraction slowed down

In Q4, Scanfil's revenue decreased by 4% to 202 MEUR from a relatively good comparison level. Organically, we estimate revenue declined by just under 10%, as the SRX acquisition supported revenue from the beginning of October. However, revenue development was slightly better than our forecasts in the latter part of the year, driven by somewhat better-than-expected traction in all three customer segments. However, the company sold almost 15 MEUR of its customer inventory in Q4, so the outperformance was not solely due to better-than-expected demand. Of the businesses, MedTech&Life Science turned to growth as expected in Q4, while Industrial and Energy&Cleantech still declined slightly in Q4.
   

A fairly good operating performance continued in Q4

Scanfil’s adjusted EBIT improved in Q4 by some 4% to 14.0 MEUR driven by the SRX acquisition and the company’s efficiency measures. The result settled around the lower end of the guidance, practically in line with out estimate. Profitability (EBIT %) was at a reasonable level on Scanfil's scale at 6.6%, considering the dilutive impact of low-margin inventory sales on profitability (cf. in the comparison period, the margin was burdened by non-recurring costs related to restructuring). The company has alleviated the pressure on earnings caused by the decline in revenue relatively well through savings and efficiency measures. 

On the bottom line, Scanfil recorded marginal adjustment items for Q4 related to the SRX acquisition, and financial expenses were higher than our expectations, probably mainly due to currency-based and non-cash reasons. The tax rate was also slightly above our expectations. Thus, Scanfil’s EPS decreased clearly in Q4 from the comparison period to EUR 0.14 per share and was also below our forecast, which expected a more moderate decline. From a cash flow perspective, the report looks quite good at first glance, and net debt at the end of last year was roughly in line with our expectations. 

Forecasts are roughly in the middle of the guidance ranges

Scanfil gave guidance for the current year, according to which the company's 2025 revenue will be 780-920 MEUR and adjusted EBIT 53-66 MEUR. Prior to the report, we expected Scanfil's revenue to grow by 9% to 844 MEUR and adjusted EBIT to grow by 11% to 59 MEUR. We also suspect that consensus forecasts were roughly similar. Thus, we believe the current year outlook is sufficient to meet expectations, although the relatively wide ranges reflect, in our view, the uncertainty still related to the near-term outlook, especially regarding external factors. This year, Scanfil's revenue and earnings growth will be supported by the SRX acquisition and new projects won last year (a total of 188 MEUR, no comparison figure available). In addition, the general demand situation should slowly recover with the global and European economies. Based on the comments, the company still has an appetite for acquisitions, so we would not be surprised if the support from inorganic growth on the figures strengthens further during the year. The balance sheet also offers plenty of capacity to continue acquisitions.

Scanfil

8,29EUR2025-02-20 18:00
8,70EURRiktkurs
Öka
Recommendation updated:2024-10-27

Scanfil är en internationell tillverkare av elektronikkontrakt, specialiserat inom industri- och B2B-kunder. Tjänsterna inkluderar tillverkning av slutprodukter och komponenter såsom PCB. Tillverkningstjänster är kärnan i bolaget med stöd av design, leveranskedja och moderniseringstjänster. Bolaget verkar globalt i Europa, Amerika och Asien. Kunderna återfinns främst inom processautomation, energieffektivitet, grön-effektivitet och medicinska segment.

Read more on company page

Key Estimate Figures2024-10-27

202324e25e
202324e25e
Omsättning901,5772,7844,0
tillväxt-%6,8 %−14,3 %9,2 %
EBIT (adj.)61,353,058,7
EBIT-%6,8 %6,9 %7,0 %
EPS (adj.)0,740,610,68
Utdelning0,230,250,27
Direktavkastning2,9 %2,8 %3,0 %
P/E (just.)10,614,513,0
EV/EBITDA7,08,27,1
Forum uppdateringar
Scanfil investerar i en ny produktionslinje för elektronik vid sin fabrik i Atlanta, USA. Inderes Scanfil investerar i en production line fö...
för 3 timmar sedan
by börsen84
0
My Scanfil is about to release its Q1 results soon — what does the analyst have to say…? Inderes Scanfil Q1'25 earnings preview: Ramp-up of ...
2025-04-23 22:31
by börsen84
0
This is now a comprehensive, high-quality, and easy-to-read analysis of Scanfil! Inderes Scanfil Extensive Report: Topline-driven value creation...
2025-04-10 13:43
by börsen84
0
Inderes Scanfil Q4’24: No room for surprises - Inderes Time: 2025-02-26 09:54 Scanfil’s performance is showing signs of a turnaround. In Q4,...
2025-02-27 10:33
by Isa Hudd
1
Enligt Inderes analys verkar Scanfil’s resultatutveckling ha vänt i en positiv riktning, och risknivån har sjunkit något, vilket stödjer värderingen...
2025-02-24 23:29
by börsen84
1
Scanfil Q4-rapport motsvarade förväntningarna utan några stora överraskningar. Omsättningen minskade med 4 %, men den organiska nedgången saktade...
2025-02-21 22:36
by börsen84
0
Scanfil resultat på fredag, prekommentar ute nu! Direktlänk nedan: Inderes Scanfil Q4'24 preview: Forecasts show a moderate turnaround for Q4...
2025-02-19 13:13
by Isa Hudd
1
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Our team
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

Sekretessinställningar

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.